A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2788-2797

  Wang, Tuanlao ^a   Zhang, Ming ^a   Ma, Zexu ^a   Guo, Ke ^b   Tergaonkar, Vinay ^b   Zeng, Qi ^b   Hong, Wanjin ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; PROTEIN KINASE B; PROTEOME; RAB7 PROTEIN; SHORT HAIRPIN RNA; VASCULOTROPIN RECEPTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROTECTION; DEGRADATION KINETICS; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

ANIMALS; ANOIKIS; APOPTOSIS; BENZOQUINONES; CELL PROLIFERATION; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC VECTORS; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; LENTIVIRUS; LEUPEPTINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-AKT; RAB GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR BURDEN;

EID: 84863115707     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23023     Document Type: Article

References (60)

1. Andres DA, Seabra MC, Brown MS, Armstrong SA, Smeland TE, Cremers FP, Goldstein JL. 1993. cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell 73:1091-1099.
2. Akca H, Tani M, Hishida T, Matsumoto S, Yokota J. 2006. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells. Lung Cancer 54:25-33.
3. Bingol B, Schuman EM. 2005. Synaptic protein degradation by the ubiquitin proteasome system. Curr Opin Neurobiol 15:536-541.
4. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M. 1992. The small GTPase Rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70:715-728.
5. Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. 2000. Rab7: A key to lysosome biogenesis. Mol Biol Cell 11:467-480.
6. Cascone T, Morelli MP, Ciardiello F. 2006. Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer. Ann Oncol 17:ii46-ii48.
7. Ceresa BP, Bahr SJ. 2006. Rab7 activity affects epidermal growth factor: Epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. J Biol Chem 281:1099-1106.
8. Chavrier P, Goud B. 1999. The role of ARF and Rab GTPases in membrane transport. Curr Opin Cell Biol 11:466-475.
9. Chen CY, Balch WE. 2006. The Hsp90 chaperone complex regulates GDI-dependent Rab recycling. Mol Biol Cell 17:3494-3507.
10. de Candia P, Solit DB, Giri D, Brogi E, Siegel PM, Olshen AB, Muller WJ, Rosen N, Benezra R. 2003. Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc Natl Acad Sci USA 100:12337-12342.
11. Dowell JE, Minna JD. 2006. EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer. Nat Clin Pract Oncol 3:170-171.
12. Drysdale MJ, Brough PA, Massey A, Jensen MR, Schoepfer J. 2006. Targeting Hsp90 for the treatment of cancer. Curr Opin Drug Discov Devel 9:483-495.
13. Duvernay MT, Filipeanu CM, Wu G. 2005. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal 17:1457-1465.
14. Edinger AL. 2005. Growth factors regulate cell survival by controlling nutrient transporter expression. Biochem Soc Trans 33:225-227.
15. Edinger AL, Cinalli RM, Thompson CB. 2003. Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression. Dev Cell 5:571-582.
16. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. 1996. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134:793-799.
17. Greulich H, Chen TH, Feng W, Jänne PA, Alvarez JV, Zappaterra M, Bulmer SE, Frank DA, Hahn WC, Sellers WR, Meyerson M. 2005. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med 2:e313.
18. Goldberg AL. 2007. Functions of the proteasome: From protein degradation and immune surveillance to cancer therapy. Biochem Soc Trans 35:12-17.
19. Imai J, Maruya M, Yashiroda H, Yahara I, Tanaka K. 2003. The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBO J 22:3557-3567.
20. Kesarwala AH, Samrakandi MM, Piwnica-Worms D. 2009. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation. Cancer Res 69:976-983.
21. Lackner MR, Kindt RM, Carroll PM, Brown K, Cancilla MR, Chen C, de Silva H, Franke Y, Guan B, Heuer T, Hung T, Keegan K, Lee JM, Manne V, O'Brien C, Parry D, Perez-Villar JJ, Reddy RK, Xiao H, Zhan H, Cockett M, Plowman G, Fitzgerald K, Costa M, Ross-Macdonald P. 2005. Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors. Cancer Cell 7:325-336.
22. Lawlor MA, Alessi DR. 2001. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903-2910.
23. Li Z, Zhao J, Du Y, Park HR, Sun SY, Bernal-Mizrachi L, Aitken A, Khuri FR, Fu H. 2008. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci USA 105:162-167.
24. Liotta LA, Kohn E. 2004. Anoikis: Cancer and the homeless cell. Nature 430:973-974.
25. Lombardi D, Soldati T, Riederer MA, Goda Y, Zerial M, Pfeffer SR. 1993. Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J 12:677-682.
26. Lord JM. 1996. Go outside and see the proteasome. Protein degradation. Curr Biol 6:1067-1069.
27. Marmor MD, Yarden Y. 2004. Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23:2057-2070.
28. Marte BM, Downward J. 1997. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355-358.
29. O'Donovan N, Crown J. 2007. EGFR and HER-2 antagonists in breast cancer. Anticancer Res 27:1285-1294.
30. Ogino A, Kitao H, Hirano S, Uchida A, Ishiai M, Kozuki T, Takigawa N, Takata M, Kiura K, Tanimoto M. 2007. Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line. Cancer Res 67:7807-7814.
31. Olkkonen VM, Stenmark H. 1997. Role of Rab GTPases in membrane traffic. Int Rev Cytol 176:1-85.
32. Orford K, Orford CC, Byers SW. 1999. Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146:855-868.
33. Padilla BE, Cottrell GS, Roosterman D, Pikios S, Muller L, Steinhoff M, Bunnett NW. 2007. Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins. J Cell Biol 179:981-997.
34. Pfeffer SR. 2001. Rab GTPases: Specifying and deciphering organelle identity and function. Trends Cell Biol 11:487-491.
35. Polo S, Pece S, Di Fiore PP. 2004. Endocytosis and cancer. Curr Opin Cell Biol 16:156-161.
36. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, Muthuswamy SK, Brugge JS. 2003. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5:733-740.
37. Romero Rosales K, Peralta ER, Guenther GG, Wong SY, Edinger AL. 2009. Rab7 activation by growth factor withdrawal contributes to the induction of apoptosis. Mol Biol Cell 20:2831-2840.
38. Sartore-Bianchi A, Cerea G, Schiavetto I, Giannetta L, Ricotta R, Maugeri MR, Moroni M, Marrapese G, Siena S. 2006. Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer. Ann Oncol 17:ii49-ii51.
39. Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL, Sellers W, Rosen N, Solit DB. 2008. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Cancer Res 68:589-596.
40. Sepp-Lorenzino L, Ma Z, Lebwohl DE, Vinitsky A, Rosen N. 1995. Herbimycin A induces the 20S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases. J Biol Chem 270:16580-16587.
41. Segev N. 2001. Ypt and Rab GTPases: insight into functions through novel interactions. Curr Opin Cell Biol 13:500-511.
42. Sharp S, Workman P. 2006. Inhibitors of the HSP90 molecular chaperone: current status. Adv Cancer Res 95:323-348.
43. Shimamura T, Lowell AM, Engelman JA, Shapiro GI. 2005. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res 65:6401-6408.
44. Smith V, Hobbs S, Court W, Eccles S, Workman P, Kelland LR. 2002. ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin. Anticancer Res 22:1993-1999.
45. Snider MD. 2003. A role for rab7 GTPase in growth factor-regulated cell nutrition and apoptosis. Mol Cell 12:796-797.
46. Somsel Rodman J, Wandinger-Ness A. 2000. Rab GTPases coordinate endocytosis. J Cell Sci 113:183-192.
47. Song G, Ouyang G, Bao S. 2005. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9:59-71.
48. Sönnichsen B, De Renzis S, Nielsen E, Rietdorf J, Zerial M. 2000. Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 149:901-914.
49. Sorkin A, Waters CM. 1993. Endocytosis of growth factor receptors. Bioessays 15:375-382.
50. Strous GJ, van Kerkhof P. 2002. The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability. Mol Cell Endocrinol 197:143-151.
51. Tiscornia G, Singer O, Ikawa M, Verma IM. 2003. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 100:1844-1848.
52. Tiscornia G, Singer O, Verma IM. 2006a. Design and cloning of lentiviral vectors expressing small interfering RNAs. Nat Protoc 1:234-240.
53. Tiscornia G, Singer O, Verma IM. 2006b. Production and purification of lentiviral vectors. Nat Protoc 1:241-245.
54. Tokunaga E, Kimura Y, Oki E, Ueda N, Futatsugi M, Mashino K, Yamamoto M, Ikebe M, Kakeji Y, Baba H, Maehara Y. 2006. Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int J Cancer 118:284-289.
55. Ullrich O, Reinsch S, Urbé S, Zerial M, Parton RG. 1996. Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol 135:913-924.
56. van der Sluijs P, Hull M, Webster P, Mâle P, Goud B, Mellman I. 1992. The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 70:729-740.
57. Vikis H, Sato M, James M, Wang D, Wang Y, Wang M, Jia D, Liu Y, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, Rothschild H, Mandal D, Kupert E, Seminara D, Viswanathan A, Govindan R, Minna J, Anderson MW, You M. 2007. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 67:4665-4670.
58. Wang T, Hong W. 2002. Interorganellar regulation of lysosome positioning by the Golgi apparatus through Rab34 interaction with Rab-interacting lysosomal protein. Mol Biol Cell 13:4317-4332.
59. Zerial M, McBride H. 2001. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2:107-117.
60. Zhang H. 2003. Binding platforms for Rab prenylation and recycling: Rab escort protein, RabGGT, and RabGDI. Structure 11:237-239.